Resting state functional Magnetic Resonance Imaging (rdFMRI) is a type of functional brain imaging used to measure resting-state activity in a person’s brain. This form of imaging tracks the changes in brain activity that occur during times of rest or when the person is not actively engaged in a task. It is an important tool in neuroscience, neuroimaging and clinical research to better understand how the brain works and how various components of the brain interact with one another. rdFMRI offers an insight into the connectivity of the brain. It is able to look at which regions of the brain are connected more strongly than others in a resting state. This helps researchers identify the structural networks within the brain that are responsible for normal motor and cognitive functioning. For example, recent research using rdFMRI has identified structural networks that are thought to be involved in attention, motor control, language processing, and emotion regulation. rdFMRI has also allowed researchers to identify disrupted brain networks in patients with various psychological disorders. By looking at the connectivity of the brain, researchers are able to detect differences in resting-state networks in people with diseases such as depression, anxiety, and schizophrenia. This provides further insight into how these disorders might be caused by abnormalities in brain networks or functioning. Overall, rdFMRI is a powerful tool to gain insight into the structure and function of the brain. It provides researchers with a better understanding of how the brain works and how various diseases can impact the normal function of the brain. Through rdFMRI, researchers can better understand how psychological diseases involve disruptions in brain networks that cause cognitive and motor difficulties, helping them to develop treatments that target the underlying cause of dysfunction.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States